Medically reviewed by Brian Bezack, DO Inhalers are medical devices used to deliver a dose of medication into your lungs to ...

Opens in a new tab or window There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

AsrtaZeneca and GSK are currently developing the so-called green inhalers, which don’t rely on hydrofluorocarbons, or HFCs, as propellants to push the medicine into patients’ lungs ...

Spiriva capsules contain 18 mcg of tiotropium and are light green ... other than inhaled anticholinergics. The coprimary endpoints were the proportion of patients with COPD exacerbation and ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...